South Korea CRISPR Diagnostics Market Insight
Published: 03 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The South Korean CRISPR diagnostics market is expected to expand at compound annual growth rate (CAGR) of 16.02% between 2025-2035, driven by demand for precision medicine and adoption of cancer screening.
South Korea CRISPR Diagnostics Market Insights Forecasts to 2035
- The South Korea CRISPR Diagnostics Market Size Was Estimated USD 41.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 16.02% from 2025 to 2035
- The South Korea CRISPR Diagnostics Market Size is Expected to rise around USD 184.7 Million by 2035
Notable Insights for the South Korea CRISPR Diagnostics Market
- According to application segmentation, infectious illness testing is growing quickly due to post-pandemic demands and advances in liquid biopsy, while cancer diagnostics is leading.
- CRISPR-based detection kits are the most popular based on product segmentation, however next-generation sequencing integrated platforms are rapidly developing for multi-cancer screening.
- In order to boost gene-editing diagnostics and infrastructure, the Korean government set aside KRW 361 billion (about USD 276 million) for the development of biomedical technologies in 2025.
- GeneCker was awarded KRW 15 billion, or roughly USD 10.2 million. Strong investor confidence in CRISPR-based liquid biopsy is demonstrated by the February 2026 Series C investment.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- AI-Driven CRISPR Diagnostics Intelligence & Precision Medicine Insights
Decision Advisors offers state-of-the-art AI-driven research on the use of CRISPR technology, liquid biopsy tests, and genomics testing. Opportunities for growth in diagnostic laboratories, hospitals, and biotech companies are evaluated through advanced data analytics and forecasting in the South Korea CRISPR diagnostics market.
- Robust Research Methodology with Accurate Forecasting Models
The research includes interviews with diagnostic developers, doctors, and hospital administrators along with secondary sources including data on regulations, clinical trials, and industry publications. In the case of the South Korea CRISPR diagnostics market, it ensures accurate figures and forecasts as well as technology adoption data.
- Comprehensive Competitive and Ecosystem Analysis
This report analyzes key diagnostic players, CRISPR technology providers, and liquid biopsy companies. It offers detailed insight into competitive positioning, strategic hospital collaborations, regulatory advancements, and future prospects within the South Korean market for precision diagnostics.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea CRISPR diagnostics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea CRISPR Diagnostics Market
- GeneCker
- ToolGen
- Bioneer Corporation
- Genolution
- Seegene Inc.
- SD Biosensor
- Roche Diagnostics Korea
- Thermo Fisher Scientific Korea
- Illumina Korea
- Qiagen Korea
Recent Developments:
- In March 2025, to develop CRISPR-Cas gene-editing and molecular diagnostic technologies for precision medical applications, ToolGen entered into a research partnership with top South Korean academic institutions.
- In June 2024, bioneer strengthened capabilities relevant to CRISPR-based diagnostic workflows by adding additional gene analysis and nucleic acid detection kits to its molecular diagnostics range.
Market Segmentation:
South Korea CRISPR Diagnostics Market, By Product Type
- CRISPR-Based Detection Kits
- CRISPR-Integrated Sequencing Platforms
- Liquid Biopsy Solutions
South Korea CRISPR Diagnostics Market, By End-User
-
- Hospitals & Diagnostic Labs
- Biotechnology Companies
- Research Institutes
South Korea CRISPR Diagnostics Market, By Application
-
- Cancer Diagnostics
- Infectious Disease Testing
- Genetic Disorder Screening
- Pharmacogenomics
Expert Views:
The CRISPR diagnostics industry in South Korea is set for strong growth, driven by developments in precision medicine, molecular diagnostics, and investments by the government in biotechnology. Integration of CRISPR diagnostics with the next generation sequencing techniques and liquid biopsies is likely to boost accuracy of diagnosis. Collaboration, regulation, and innovation are some factors that will contribute to market competitiveness.
Author: Govind and Krishna By Decisions Advisors and Consulting